Can a malaria drug help kids with rare lung disease?
NCT ID NCT04532346
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether hydroxychloroquine, a drug used for malaria and arthritis, can safely improve breathing in children with interstitial lung disease caused by genetic mutations. Researchers will enroll 60 children and randomly assign them to receive the drug or not, measuring oxygen levels and breathing rates. The goal is to see if the drug reduces symptoms like coughing and breathing difficulty.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- hydroxychloroquine
- What this could lead to
- If it works, this could point toward a treatment to improve breathing and reduce symptoms in children with genetic lung disease.
- What could go wrong
- This is a very early, small trial (60 children) with no guarantee of success. Hydroxychloroquine may not work for these rare conditions and could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDREN'S INTERSTITIAL LUNG DISEASE WITH GENETIC CAUSES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's hospital of Fudan University
RECRUITINGShanghai, Shanghai Municipality, 201102, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI catch lung scarring that doctors might miss?
- Could lying on the stomach help infants breathe easier?
- Can arm workouts boost oxygen use in lung disease?
- Spotting hidden blood clots in scarred lungs: a study hunts for clues
- Virtual Nurse-Social worker team aims to ease symptoms for veterans with heart failure and COPD
- AI outruns radiologists in detecting early lung scarring